IP Library Granted Patent US 11,390,846
Granted Patent B2
US 11,390,846 · App. 16/654,952 · Granted Jul 19, 2022

Methods for controlled induction of 3D cylindrical neuroepithelial tubes

Inventors: Randolph Scott Ashton (Madison, WI); Carlos Ruben Marti-Figueroa (Madison, WI)
Assignee: Wisconsin Alumni Research Foundation
C12N5/0618C12N5/0062C12N2500/05C12N2500/32C12N2500/38C12N2501/33C12N2501/999C12N2506/02C12N2506/03C12N2506/45C12N2513/00C12N2533/18C12N2533/30C12N2533/74C12N2537/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,390,846
App. No.
16/654,952
Granted
Jul 19, 2022
Kind
B2
Abstract

Described herein are methods, compositions, and kits for forming engineered in vitro biomimetic, three-dimensional, tubular organoid structures by directed differentiation of human pluripotent stem cells within tubular channels formed in a hydrogel.

Claims (29)

1. A method of preparing an engineered biomimetic 3 D organoid in vitro, the method comprising:

(a) providing a hydrogel having a channel therein, the channel having a first end and a second end;

(b) sealing one or more of the first and second ends of the channel;

(c) seeding the channel with human pluripotent stem cells (hPSCs),

(d) contacting the hydrogel comprising the hPSC-seeded channel to an alginate solution, and then contacting the alginate-contacted hydrogel to a divalent cation solution, thereby producing a hPSC-seeded channel encapsulated in crosslinked hydrogel, and

(e) culturing the encapsulated hPSC-seeded channel in a culture medium for about four (4) to about sixteen (16) days for the hPSCs within the channel to differentiate into neuroepithelial cells, whereby a biomimetic 3D organoid comprising polarized neuroepithelial cells and having microscale cellular organization similar to that of an in vivo developing human neural tube is obtained.

2. The method of claim 1 , wherein the hydrogel is an alginate hydrogel.

3. The method of claim 1 , wherein the divalent cation solution is a calcium chloride (CaCl 2 ) solution.

4. The method of claim 1 , wherein sealing comprises contacting the first end or the second end of the channel to an alginate solution and contacting the alginate-contacted end to a divalent cation solution, thereby producing a channel comprising a sealed end and an unsealed end.

5. The method of claim 4 , wherein seeding the channel comprises injecting a hPSC suspension having a cell density of about 500,000 cells/μl or less into the unsealed end.

6. The method of claim 1 , wherein sealing comprises contacting the first end and the second end of the channel into an alginate solution and contacting each alginate- contacted end into a divalent cation solution, thereby producing a channel comprising a first sealed end and a second sealed end.

7. The method of claim 6 , wherein seeding the channel comprises injecting a hPSC suspension having a cell density of about 500,000 cells/μl or less into the first sealed end or the second sealed end.

8. The method of claim 7 , further comprising re-sealing the end into which the hPSC suspension is injected, wherein re-sealing comprises;

contacting an alginate solution to the hPSC suspension-injected end; and

contacting the alginate-contacted end to a divalent cation solution to cross-link the alginate, thereby producing a hPSC-seeded channel comprising a sealed end and a re-sealed end.

9. The method of claim 1 , wherein the biomimetic 3D organoid is a biomimetic neuroepithelial organoid comprising polarized neural stem cells.

10. The method of claim 1 , wherein the channel is substantially tubular.

11. The method of claim 10 , wherein the diameter of the substantially tubular channel is between about 50 μm to about 700 μm.

12. The method of claim 10 , wherein the diameter of the substantially tubular channel is between about 100 μm to about 300 μm.

13. The method of claim 1 , wherein the culture medium is sufficient to promote the self-organization and spontaneous morphogenesis of the hPSCs into neuroepithelial organoids.

14. The method of claim 13 , wherein the culture medium is a neural differentiation medium comprising water, salts, amino acids, vitamins, a carbon source, a buffering agent, selenium, ascorbate, insulin, transferrin, and a Rho kinase (ROCK) inhibitor.

15. The method of claim 14 , wherein the hydrogel comprising the cell-seeded channel is cultured within a spinner flask containing the neural differentiation medium.

16. The method of claim 1 , wherein the hydrogel is produced by the method comprising:

(a) providing a sacrificial template of a predefined shape immobilized within a casting chamber,

(b) introducing into the casting chamber a volume of hydrogel polymer solution sufficient to surround the sacrificial template,

(c) contacting the hydrogel polymer with a cross-linking solution to form a hydrogel shell surrounding the sacrificial template, and

(d) removing the sacrificial template, thereby providing a hydrogel with a channel therein.

17. The method of claim 16 , wherein the sacrificial template is a water soluble thermoplastic-divalent cationic salt composite material.

18. The method of claim 16 , wherein the sacrificial template is poly(vinyl alcohol) material coated in divalent cations.

Assignments (2)
CONFIRMATORY LICENSE Recorded Oct 18, 2019
From: UNIVERSITY OF WISCONSIN, MADISON
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 050767/0368 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 17, 2019
From: ASHTON, RANDOLPH; MARTI-FIGUEROA, CARLOS
To: WISCONSIN ALUMNI RESEARCH FOUNDATION
Reel/Frame 050755/0209 →
Continuity (2)
Provisional Application 62746373 · Oct 16, 2018
Related Publication 20200115677A1 · Apr 16, 2020